E

Emergence Therapeutics

11 employees

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Wellness
Fitness

Date founded

2019

Funding rounds raised

Total raised

$98M

from 8 investors over 8 rounds

E

Emergence Therapeutics raised $98M on December 7, 2021

Investors: Hadean Ventures, OrbiMed Advisors, Surveyor Capital, RA Capital Management, L.P., NRW.BANK, High-Tech Gründerfonds, Gründerfonds Ruhr and Pontifax Venture Capital

FAQ